4-1012561-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004356.3(FGFRL1):āc.76C>Gā(p.Arg26Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,424,098 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001004356.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFRL1 | NM_001004356.3 | c.76C>G | p.Arg26Gly | missense_variant | 2/7 | ENST00000510644.6 | NP_001004356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFRL1 | ENST00000510644.6 | c.76C>G | p.Arg26Gly | missense_variant | 2/7 | 1 | NM_001004356.3 | ENSP00000425025.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152136Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000175 AC: 16AN: 91572Hom.: 0 AF XY: 0.000135 AC XY: 7AN XY: 51844
GnomAD4 exome AF: 0.000238 AC: 303AN: 1271852Hom.: 1 Cov.: 20 AF XY: 0.000245 AC XY: 155AN XY: 631406
GnomAD4 genome AF: 0.000145 AC: 22AN: 152246Hom.: 0 Cov.: 34 AF XY: 0.0000940 AC XY: 7AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.76C>G (p.R26G) alteration is located in exon 2 (coding exon 1) of the FGFRL1 gene. This alteration results from a C to G substitution at nucleotide position 76, causing the arginine (R) at amino acid position 26 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1485221). This variant has not been reported in the literature in individuals affected with FGFRL1-related conditions. This variant is present in population databases (rs768315040, gnomAD 0.05%). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 26 of the FGFRL1 protein (p.Arg26Gly). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at